183 related articles for article (PubMed ID: 8555936)
21. Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare".
Heinemann LA; Dinger JC; Assmann A; Minh TD
Contraception; 2010 May; 81(5):401-7. PubMed ID: 20399946
[TBL] [Abstract][Full Text] [Related]
22. Third generation oral contraception and venous thromboembolism.
McPherson K
BMJ; 1996 Jan; 312(7023):68-9. PubMed ID: 8555921
[No Abstract] [Full Text] [Related]
23. Oral contraception and venous thromboembolism. A New Zealand perspective.
Roke C
Drug Saf; 1997 Feb; 16(2):79-87. PubMed ID: 9067120
[TBL] [Abstract][Full Text] [Related]
24. Risk of acute myocardial infarction and low-dose combined oral contraceptives.
Jick H; Jick S; Myers MW; Vasilakis C
Lancet; 1996 Mar; 347(9001):627-8. PubMed ID: 8596366
[No Abstract] [Full Text] [Related]
25. The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study.
Dunn NR; Arscott A; Thorogood M
Contraception; 2001 Feb; 63(2):65-9. PubMed ID: 11292469
[TBL] [Abstract][Full Text] [Related]
26. Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study.
Thorogood M; Mann J; Murphy M; Vessey M
Br J Obstet Gynaecol; 1991 Dec; 98(12):1245-53. PubMed ID: 1777457
[TBL] [Abstract][Full Text] [Related]
27. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1995 Dec; 346(8990):1575-82. PubMed ID: 7500748
[TBL] [Abstract][Full Text] [Related]
28. [Arterial diseases in women using combined hormonal contraceptives].
Novotná M; Unzeitig V; Novotný T
Ceska Gynekol; 2002 May; 67(3):157-63. PubMed ID: 12078552
[TBL] [Abstract][Full Text] [Related]
29. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1995 Dec; 346(8990):1582-8. PubMed ID: 7500749
[TBL] [Abstract][Full Text] [Related]
30. [Oral contraceptives and risk of myocardial infarction].
Sørensen MB; Ottesen BS
Ugeskr Laeger; 2002 Apr; 164(18):2415-6. PubMed ID: 12024850
[No Abstract] [Full Text] [Related]
31. Low dose combined oral contraceptives induced thrombotic anterior wall myocardial infarction: a case report.
Rahhal A; Khir F; Adam M; Aljundi A; Mohsen MK; Al-Suwaidi J
BMC Cardiovasc Disord; 2020 Apr; 20(1):182. PubMed ID: 32306901
[TBL] [Abstract][Full Text] [Related]
32. Instrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptives.
Boef AG; Souverein PC; Vandenbroucke JP; van Hylckama Vlieg A; de Boer A; le Cessie S; Dekkers OM
Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):317-24. PubMed ID: 26749045
[TBL] [Abstract][Full Text] [Related]
33. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
Lidegaard O
BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
[TBL] [Abstract][Full Text] [Related]
34. The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect.
Lewis MA
Hum Reprod Update; 1999; 5(6):707-20. PubMed ID: 10652980
[TBL] [Abstract][Full Text] [Related]
35. Benefits and risks of third-generation oral contraceptives.
Leblanc ES; Laws A
J Gen Intern Med; 1999 Oct; 14(10):625-32. PubMed ID: 10571709
[TBL] [Abstract][Full Text] [Related]
36. Oral contraceptives and venous thromboembolism: an epidemiological review.
Lidegaard O
Eur J Contracept Reprod Health Care; 1996; 1(1):13-20. PubMed ID: 9678133
[TBL] [Abstract][Full Text] [Related]
37. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
[TBL] [Abstract][Full Text] [Related]
38. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
Rekers H; Norpoth T; Michaels MA
Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
[TBL] [Abstract][Full Text] [Related]
39. The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives.
Nightingale AL; Lawrenson RA; Simpson EL; Williams TJ; MacRae KD; Farmer RD
Eur J Contracept Reprod Health Care; 2000 Dec; 5(4):265-74. PubMed ID: 11245554
[TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
Urbanus RT; Siegerink B; Roest M; Rosendaal FR; de Groot PG; Algra A
Lancet Neurol; 2009 Nov; 8(11):998-1005. PubMed ID: 19783216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
